Simple jQuery Dropdowns

Browsing by Author Richard S. Finn

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 2 of 2
Issue DateTitleAuthor(s)
1-Jan-2014Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trialMasatoshi Kudo; Guohong Han; Richard S. Finn; Ronnie T.P. Poon; Jean Frederic Blanc; Lunan Yan; Jijin Yang; Ligong Lu; Won Young Tak; Xiaoping Yu; Joon Hyeok Lee; Shi Ming Lin; Changping Wu; Tawesak Tanwandee; Guoliang Shao; Ian B. Walters; Christine Dela Cruz; Valerie Poulart; Jian Hua Wang; Kindai University School of Medicine; The Fourth Military Medical University; David Geffen School of Medicine at UCLA; The University of Hong Kong; CHU Hopitaux de Bordeaux; West China Hospital of Sichuan University; Changhai Hospital; Guangdong General Hospital; Kyungpook National University Hospital; Hunan Provincial Tumor Hospital; SungKyunKwan University, School of Medicine; Chang Gung Memorial Hospital; First People's Hospital of Changzhou; Mahidol University; Zhejiang Cancer Hospital; Bristol-Myers Squibb; Bristol-Myers Squibb; Zhongshan Hospital Shanghai
20-Jan-2018Phase II study of BGJ398 in patients with FGFR-Altered advanced cholangiocarcinomaMilind Javle; Maeve Lowery; Rachna T. Shroff; Karl Heinz Weiss; Christoph Springfeld; Mitesh J. Borad; Ramesh K. Ramanathan; Lipika Goyal; Saeed Sadeghi; Teresa Macarulla; Anthony El-Khoueiry; Robin Kate Kelley; Ivan Borbath; Su Pin Choo; Do Youn Oh; Philip A. Philip; Li Tzong Chen; Thanyanan Reungwetwattana; Eric Van Cutsem; Kun Huei Yeh; Kristen Ciombor; Richard S. Finn; Anuradha Patel; Suman Sen; Dale Porter; Randi Isaacs; Andrew X. Zhu; Ghassan K. Abou-Alfa; Tanios Bekaii-Saab; National Cheng Kung University Hospital; Barbara Ann Karmanos Cancer Institute; National Cancer Centre, Singapore; KU Leuven– University Hospital Leuven; UCSF Helen Diller Family Comprehensive Cancer Center; Mayo Clinic Scottsdale-Phoenix, Arizona; National Taiwan University College of Medicine; Faculty of Medicine, Ramathibodi Hospital, Mahidol University; Keck School of Medicine of USC; University of Texas MD Anderson Cancer Center; Seoul National University; Cliniques Universitaires Saint-Luc, Brussels; Hospital Universitari Vall d'Hebron; Memorial Sloan-Kettering Cancer Center; David Geffen School of Medicine at UCLA; Ohio State University; Universitätsklinikum Heidelberg; Massachusetts General Hospital Cancer Center; Novartis Pharmaceuticals Corporation